Browse articles from EyeWorld.org related to keratoconus. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves biosimilar to treat wet AMD
➤ First patient dosed in Phase 1/2 study for infectious conjunctivitis
➤ First patient dosed in Phase 3 trial for investigational retinitis pigmentosa treatment
➤ Orphan Drug Designation granted to investigational retinitis pigmentosa therapy
➤ FDA Advisory Committee meets, hears public comments about atropine drop
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
U.S. ophthalmologists who have used the Epioxa system (Glaukos) for an epithelium-on crosslinking approach are excited to share their insights on this new option that they think will be safer for patients, facilitate faster healing, and could potentially stop progression of keratoconus sooner.
The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus across pediatric, adolescent, and adult populations in a diverse U.S. population” from the September issue of the Journal of Cataract & Refractive Surgery.
➤ AMA classifies myopia as a disease
➤ Report marks shift in refractive surgery trends
➤ Patient dosing begins in Phase 2 trial for oral DME therapy
➤ ASCRS news and events
➤ EyeWorld article of the week
Corneal tissues procedures are one of the approaches available to help treat corneal conditions, like keratoconus, and offer some patients an option other than transplantation. Several experts discussed these procedures, how they fit in with other options, and how they’re being utilized today.
➤ Topline results from Phase 2/3 study for uveal melanoma treatment
➤ Study evaluates spatial computing in cataract surgery with Apple Vision Pro
➤ Updates in DME treatment trials
➤ Company news
➤ ASCRS news and events
➤ FDA issues another response letter for dry eye NDA
➤ FDA denies approval for LHON NDA
➤ Commercial launch of epithelium-on crosslinking in the U.S.
➤ Company news
➤ ASCRS news and events
➤ Enrollment complete in Phase 3 trial for wet AMD
➤ Dosing complete in Phase 1/2 trial for retinitis pigmentosa treatment
➤ First patient dosed in gene therapy study for optic nerve disorder
➤ Company news
➤ FDA approves epithelium-on crosslinking treatment
➤ 12-month results from Phase 1/2 trial evaluating regenerative cell therapy for corneal endothelial disease
➤ Phase 3 data supports nonsteroidal treatment for uveitic macular edema
➤ FDA approves IDE for glaucoma device
➤ Company news
➤ ASCRS news and events
Two physicians discussed finding the right refraction in patients with keratoconus, what to take into account, and considerations if patients are seeking surgery.
